Epidemiology and etiology: An overview

Research output: Contribution to journalArticle

Abstract

Epilepsy is common, with an estimated lifetime incidence of 3%. Regardless of etiology, epilepsy is associated with increased mortality, particularly among those with poorly controlled seizures. Furthermore, recent research indicates that 44% of patients have poorly controlled seizures despite treatment. The epilepsies also have far-reaching burdens including an annual cost of $12.5 billion in the United States, and social and professional challenges for patients requiring a comprehensive treatment approach. One current controversy surrounding epilepsy are proposed changes to the International League Against Epilepsy diagnostic guidelines advocating lessened dependence on electroencephalogram findings and lessened use of loss of consciousness in order to classify epilepsy and seizure types. Another emerging issue is the importance of choice of agent and timing of treatment initiation for newly presenting seizure cases. The potential difficulties in changing a drug regimen at a later date along with specific needs of special populations such as the elderly, pregnant women, and those with comorbid conditions or the potential for drug interactions must be taken into account.

Original languageEnglish (US)
JournalAdvanced Studies in Medicine
Volume5
Issue number1 B
StatePublished - Jan 2005

Fingerprint

Epilepsy
Epidemiology
Seizures
Unconsciousness
Drug Interactions
Pregnant Women
Electroencephalography
Therapeutics
Guidelines
Costs and Cost Analysis
Mortality
Incidence
Research
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epidemiology and etiology : An overview. / Kaplan, Peter W.

In: Advanced Studies in Medicine, Vol. 5, No. 1 B, 01.2005.

Research output: Contribution to journalArticle

@article{3f5fdb6de1d5412fae7d1db651743e1e,
title = "Epidemiology and etiology: An overview",
abstract = "Epilepsy is common, with an estimated lifetime incidence of 3{\%}. Regardless of etiology, epilepsy is associated with increased mortality, particularly among those with poorly controlled seizures. Furthermore, recent research indicates that 44{\%} of patients have poorly controlled seizures despite treatment. The epilepsies also have far-reaching burdens including an annual cost of $12.5 billion in the United States, and social and professional challenges for patients requiring a comprehensive treatment approach. One current controversy surrounding epilepsy are proposed changes to the International League Against Epilepsy diagnostic guidelines advocating lessened dependence on electroencephalogram findings and lessened use of loss of consciousness in order to classify epilepsy and seizure types. Another emerging issue is the importance of choice of agent and timing of treatment initiation for newly presenting seizure cases. The potential difficulties in changing a drug regimen at a later date along with specific needs of special populations such as the elderly, pregnant women, and those with comorbid conditions or the potential for drug interactions must be taken into account.",
author = "Kaplan, {Peter W}",
year = "2005",
month = "1",
language = "English (US)",
volume = "5",
journal = "Advanced Studies in Medicine",
issn = "1530-3004",
publisher = "Galen Publishing LLC",
number = "1 B",

}

TY - JOUR

T1 - Epidemiology and etiology

T2 - An overview

AU - Kaplan, Peter W

PY - 2005/1

Y1 - 2005/1

N2 - Epilepsy is common, with an estimated lifetime incidence of 3%. Regardless of etiology, epilepsy is associated with increased mortality, particularly among those with poorly controlled seizures. Furthermore, recent research indicates that 44% of patients have poorly controlled seizures despite treatment. The epilepsies also have far-reaching burdens including an annual cost of $12.5 billion in the United States, and social and professional challenges for patients requiring a comprehensive treatment approach. One current controversy surrounding epilepsy are proposed changes to the International League Against Epilepsy diagnostic guidelines advocating lessened dependence on electroencephalogram findings and lessened use of loss of consciousness in order to classify epilepsy and seizure types. Another emerging issue is the importance of choice of agent and timing of treatment initiation for newly presenting seizure cases. The potential difficulties in changing a drug regimen at a later date along with specific needs of special populations such as the elderly, pregnant women, and those with comorbid conditions or the potential for drug interactions must be taken into account.

AB - Epilepsy is common, with an estimated lifetime incidence of 3%. Regardless of etiology, epilepsy is associated with increased mortality, particularly among those with poorly controlled seizures. Furthermore, recent research indicates that 44% of patients have poorly controlled seizures despite treatment. The epilepsies also have far-reaching burdens including an annual cost of $12.5 billion in the United States, and social and professional challenges for patients requiring a comprehensive treatment approach. One current controversy surrounding epilepsy are proposed changes to the International League Against Epilepsy diagnostic guidelines advocating lessened dependence on electroencephalogram findings and lessened use of loss of consciousness in order to classify epilepsy and seizure types. Another emerging issue is the importance of choice of agent and timing of treatment initiation for newly presenting seizure cases. The potential difficulties in changing a drug regimen at a later date along with specific needs of special populations such as the elderly, pregnant women, and those with comorbid conditions or the potential for drug interactions must be taken into account.

UR - http://www.scopus.com/inward/record.url?scp=13844289317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844289317&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:13844289317

VL - 5

JO - Advanced Studies in Medicine

JF - Advanced Studies in Medicine

SN - 1530-3004

IS - 1 B

ER -